SCHEMBL1153637

SCHEMBL1153637

N#CC1(N)CCOCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6632156 0.97
SCHEMBL24620217 0.91 ALDH1A1 (0.30)
SCHEMBL3774381 0.84
SCHEMBL696010 0.78
SCHEMBL12688314 0.77 ALDH1A1 (0.35)
Hydrochloric Acid SCHEMBL1201605 0.76 ALDH1A1 (0.30)
Hydrochloric Acid SCHEMBL28038248 0.76 ALDH1A1 (0.30)
Hydrochloric Acid SCHEMBL345144 0.76
SCHEMBL4831827 0.74 KEAP1 (0.44)
Hydrochloric Acid SCHEMBL1273427 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 134 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260144743-A1 COMPOUNDS TMEM16A LIMITED (GB) 2026-05-28 US disclosed
EP-4699655-A2 COMPOUNDS TMEM16A LIMITED (GB) 2026-02-25 EP disclosed
EP-4628499-A1 POLYPEPTIDE INHIBITOR, AND PREPARATION METHOD THEREFOR AND USE THEREOF Shanghai Hansoh Biomedical Co., Ltd. (CN) 2025-10-08 EP disclosed
US-12377105-B2 Compounds TMEM16A LIMITED (GB) 2025-08-05 US disclosed
CN-114616226-B Pyridine derivatives as TMEM16A modulators for the treatment of respiratory disorders TMEM16A有限公司 2025-03-04 CN disclosed
CN-119490451-A Compounds as positive modulators of calcium activated chloride channels TMEM16A有限公司 2025-02-21 CN disclosed
CN-111683926-B Compounds of formula (I) 企业治疗学有限公司 2024-11-08 CN disclosed
US-12037324-B2 Biarylmethyl heterocycles BRISTOL-MYERS SQUIBB COMPANY (US) 2024-07-16 US disclosed
US-20240083917-A1 Polycyclic Kinase Inhibitor Xuanzhu Biopharmaceutical Co., Ltd. (CN) 2024-03-14 US disclosed
EP-4289853-A1 POLYCYCLIC KINASE INHIBITOR Shandong Xuanzhu Pharma Co., Ltd. (CN) 2023-12-13 EP disclosed
US-6271180-B2 INSECTICIDES BAYER AKTIENGESELLSCHAFT (DE) 2001-08-07 US disclosed
US-20010004629-A1 Substituted phenyl keto enols as pesticides and herbicides LIEB VOLKER (DE) 2001-06-21 US disclosed
WO-2001019816-A1 NOVEL SPIROHETEROCYCLIC COMPOUNDS USEFUL AS REVERSIBLE INHIBITORS OF CYSTEINE PROTEASES BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 2001-03-22 WO disclosed
US-6140358-A FOR CONTROLLING PESTS AND WEEDS BAYER AKTIENGESELLSCHAFT (DE) 2000-10-31 US disclosed
EP-1000036-A1 HYDANTOIN DERIVATIVES HAVING AN INHIBITORY ACTIVITY FOR FARNESYL TRANSFERASE LG CHEMICAL LIMITED (KR) 2000-05-17 EP disclosed
US-5958936-A FOR INDUCING ANTIANDROGENIC ACTIVITY IN WARM-BLOODED ANIMALS, INCLUDING HUMANS HOECHST MARION ROUSSEL (FR) 1999-09-28 US disclosed
WO-1999005117-A1 HYDANTOIN DERIVATIVES HAVING AN INHIBITORY ACTIVITY FOR FARNESYL TRANSFERASE LG CHEMICAL LTD. (KR) 1999-02-04 WO disclosed
US-5705654-A ANTIANDROGENS ROUSSEL UCLAF (FR) 1998-01-06 US disclosed
US-5646172-A Method of inducing antiandrogenic activity using imidazolidines substituted with a heterocycle ROUSSEL UCLAF (FR) 1997-07-08 US disclosed
EP-0704448-A1 Heterocyclic substituted imidazolidines, process and intermediates for their preparation, their use as medicaments and pharmaceutical compositions containing them ROUSSEL UCLAF (FR) 1996-04-03 EP disclosed